CareLit · DOI-Nachweis · Senologie - Zeitschrift für Mammadiagnostik und -therapie
Multiomic approach to determine prognosis for patients with HER2-positive breast cancer
DOI 10.1055/s-0036-1583344
Bibliografische Angaben
Nachweis in CareLit
Autor:innenPA Fasching, S Rabizadeh, F Cecchi, MW Beckmann, SY Brucker, J Golovato, A Hartmann, T Hembrough, W Janni, B Rack, Z Sanborn, A Schneeweiss, CJ Vaske, P Soon-Shiong, S Benz
ZeitschriftSenologie - Zeitschrift für Mammadiagnostik und -therapie
Ausgabe04/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Objectives: Despite improvements in the treatment of HER2-positive breast cancer (BC), almost all patients progress in the metastatic setting. We conducted the GPS Cancer test (the first CAP accredited and CLIA certified, integrated, multiomic test utilizing whole genome sequencing (WGS), RNA sequencing (RNAseq), quantitative proteomics, and pathway analysis to determine associations between tumor molecular profiles…
Zitieren
Zitierempfehlung
PA Fasching, S Rabizadeh, F Cecchi, MW Beckmann, SY Brucker, J Golovato, A Hartmann, T Hembrough, W Janni, B Rack, Z Sanborn, A Schneeweiss, CJ Vaske, P Soon-Shiong, S Benz (2016) Multiomic approach to determine prognosis for patients with HER2-positive breast cancer. Senologie - Zeitschrift für Mammadiagnostik und -therapie (04). https://doi.org/10.1055/s-0036-1583344
Mit CareLit weiterarbeiten